AI-generated summary
The authors studied 31 patients with facial melasma treated with five sessions of low-fluence 1064-nm Q-switched Nd:YAG laser at two-week intervals. They report that melasma scores, colorimetric indices and dermoscopic scores improved after treatment, with tolerable side effects. The authors conclude that dermoscopy was superior to the other assessments for diagnosis and follow-up.
- Participants
- 31
- Who or what was studied
- 31 patients with facial melasma
- Wavelengths
- 1064 nm
- Limits stated in the abstract
- The abstract does not describe a control group or the length of follow-up beyond the single post-treatment assessment at 10 weeks.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Fluence, Melanin. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.